Company registration number 14987566 (England and Wales)
DB CARDIOLOGY LIMITED
ANNUAL REPORT
AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
PAGES FOR FILING WITH REGISTRAR
DB CARDIOLOGY LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
DB CARDIOLOGY LIMITED
BALANCE SHEET
AS AT
31 JULY 2025
31 July 2025
1
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
2,516
1,775
Investments
4
84,761
-
0
87,277
1,775
Current assets
Debtors
6
43,720
18,421
Cash at bank and in hand
101,551
87,208
145,271
105,629
Creditors: amounts falling due within one year
7
(39,664)
(26,498)
Net current assets
105,607
79,131
Total assets less current liabilities
192,884
80,906
Provisions for liabilities
(554)
-
Net assets
192,330
80,906
Capital and reserves
Called up share capital
8
2
2
Profit and loss reserves
192,328
80,904
Total equity
192,330
80,906
DB CARDIOLOGY LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 JULY 2025
31 July 2025
2

For the financial year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 27 April 2026 and are signed on its behalf by:
Mr IG Diab
Director
Company registration number 14987566 (England and Wales)
DB CARDIOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
3
1
Accounting policies
Company information

DB Cardiology Limited is a private company limited by shares incorporated in England and Wales. The registered office is 7 Bournemouth Road, Chandler's Ford, Eastleigh, Hampshire, SO53 3DA.

1.1
Reporting period

The company was incorporated on 7 July 2023 and hence this first period of accounts is for the long period to 31 July 2024. Therefore the current period is not entirely comparable with the prior year.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable services provided in the normal course of business.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
Straight line 3 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand and deposits held at call with banks.

DB CARDIOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies (Continued)
4
1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

 

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
3
DB CARDIOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
5
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 August 2024
2,666
Additions
2,448
At 31 July 2025
5,114
Depreciation and impairment
At 1 August 2024
891
Depreciation charged in the year
1,707
At 31 July 2025
2,598
Carrying amount
At 31 July 2025
2,516
At 31 July 2024
1,775
4
Fixed asset investments
2025
2024
£
£
Other investments other than loans
84,761
-
0
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 August 2024
-
Additions
80,000
Valuation changes
4,761
At 31 July 2025
84,761
Carrying amount
At 31 July 2025
84,761
At 31 July 2024
-
DB CARDIOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
6
5
Financial instruments
2025
2024
£
£
Carrying amount of financial assets include:
Instruments measured at fair value through profit or loss
84,761
-
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
43,720
18,421
7
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
35,110
23,553
Other creditors
4,554
2,945
39,664
26,498
8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
of £1 each
2
2
2
2

2 Ordinary £1 shares were issued upon incorporation.

2025-07-312024-08-01falsefalsefalse27 April 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMs R BedairMr I G Diab149875662024-08-012025-07-31149875662025-07-31149875662024-07-3114987566core:OtherPropertyPlantEquipment2025-07-3114987566core:OtherPropertyPlantEquipment2024-07-3114987566core:CurrentFinancialInstrumentscore:WithinOneYear2025-07-3114987566core:CurrentFinancialInstrumentscore:WithinOneYear2024-07-3114987566core:CurrentFinancialInstruments2025-07-3114987566core:CurrentFinancialInstruments2024-07-3114987566core:ShareCapital2025-07-3114987566core:ShareCapital2024-07-3114987566core:RetainedEarningsAccumulatedLosses2025-07-3114987566core:RetainedEarningsAccumulatedLosses2024-07-3114987566core:ShareCapitalOrdinaryShareClass12025-07-3114987566core:ShareCapitalOrdinaryShareClass12024-07-3114987566bus:Director22024-08-012025-07-3114987566core:ComputerEquipment2024-08-012025-07-31149875662023-07-072024-07-3114987566core:OtherPropertyPlantEquipment2024-07-3114987566core:OtherPropertyPlantEquipment2024-08-012025-07-3114987566bus:OrdinaryShareClass12024-08-012025-07-3114987566bus:OrdinaryShareClass12025-07-3114987566bus:OrdinaryShareClass12024-07-3114987566bus:PrivateLimitedCompanyLtd2024-08-012025-07-3114987566bus:SmallCompaniesRegimeForAccounts2024-08-012025-07-3114987566bus:FRS1022024-08-012025-07-3114987566bus:AuditExemptWithAccountantsReport2024-08-012025-07-3114987566bus:Director12024-08-012025-07-3114987566bus:FullAccounts2024-08-012025-07-31xbrli:purexbrli:sharesiso4217:GBP